Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Large-scale Study Started on Antihypertensive Combination Therapy: Jikei Univ. Group
June 21, 2004
- 5 NCEs Including Octreotide to Be Included in NHI List
June 21, 2004
- Large-Scale Study on Mosapride in Functional Dyspepsia Starts
June 21, 2004
- Chuikyo Members Call For Revision of Drug Pricing Rules
June 21, 2004
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
June 21, 2004
- Korosho Holds Hearings on Progress of Action Plan
June 21, 2004
- MEDICAL DEVICE NEWS IN BRIEF
June 21, 2004
- White Paper on Manufacturing Urges International Competitiveness
June 21, 2004
- DIAGNOSTIC NEWS IN BRIEF
June 21, 2004
- REGULATORY NEWS IN BRIEF
June 21, 2004
- Iryo Proverbs Reveal Japanese Spirit (20)
June 21, 2004
- CORPORATE ROUNDUP NEWS IN BRIEF
June 21, 2004
- WORLD NEWS IN BRIEF
June 21, 2004
- 30% Copayment Rate Affecting Medical Visits: Korosho Survey
June 21, 2004
- NEW PRODUCTS
June 21, 2004
- Members of Patient Groups Show Strong Dissatisfaction with Physicians: OPIR Survey
June 21, 2004
- To Aggressively Increase Deals with Top 10 Makers: Mr Bessho of Suzuken
June 21, 2004
- PRESS SEMINAR
June 21, 2004
- Ethical Drug Market Grows 3.6% to \7.97 Trillion in FY2003: IMS Japan
June 21, 2004
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
June 21, 2004
ページ
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Adeno-associated virus (AAV) gene therapies have long been viewed as carrying only a minimal risk of insertional mutagenesis — a…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…